Clinical trial
Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram
NCT00538122 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram
- Lead sponsor
- Vanderbilt University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- September 30, 2008
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder, schizoaffective disorder, schizophrenia